Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for consciousness in ICU patients with brain damage
IRCT20141209020258N128Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of methylphenidate in traumatic brain injury (TBI) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Level of consciousness, Severity of illness and 1 more. Started Apr 2018; status: completed.
02
Drugs
methylphenidate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20141209020258N128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N128.